Stock AMARDEE6 AMERISE BIOSCIENCES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Amerise Biosciences Limited

Equities

AMARDEE6

INE673C01020

Investment Holding Companies

Market Closed - Bombay S.E.
Other stock markets
 06:00:54 2024-05-24 am EDT 		5-day change 1st Jan Change
0.63 INR +3.28% Intraday chart for Amerise Biosciences Limited +1.61% -10.00%
May. 23 Amerise Biosciences Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024 CI
Jan. 22 Amerise Biosciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI

Valuation

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Capitalization 1 62.1 56.82 54.18 109 89.85 46.25
Enterprise Value (EV) 1 61.78 56.64 53.93 108.8 90.55 47.01
P/E ratio -293 x 1,383 x -36.3 x -32.3 x 16.4 x -41.3 x
Yield - - - - - -
Capitalization / Revenue - 4,815,198 x 9,464,811,321 x -64,518,942 x 938,187 x 525,548,864 x
EV / Revenue - 4,799,599 x 9,420,915,968 x -64,404,634 x 945,464 x 534,230,682 x
EV / EBITDA - - - - - -
EV / FCF -172 x -3.18 x 1.09 x -40.6 x -62.7 x -40.2 x
FCF Yield -0.58% -31.5% 91.8% -2.46% -1.6% -2.49%
Price to Book 1.11 x 1.02 x 1 x 2.14 x 1.59 x 0.84 x
Nbr of stocks (in thousands) 66,069 66,069 66,069 66,069 66,069 66,069
Reference price 2 0.9400 0.8600 0.8200 1.650 1.360 0.7000
Announcement Date 10/16/18 8/22/19 8/24/20 8/26/21 8/29/22 9/4/23
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales - 11.8 0.005724 -1.69 95.77 0.088
EBITDA - - - - - -
EBIT 1 -0.2123 0.0411 -1.483 -3.371 5.492 -1.658
Operating Margin - 0.35% -25,902.71% 199.52% 5.73% -1,884.09%
Earnings before Tax (EBT) 1 -0.2123 0.0411 -1.483 -3.371 5.492 -1.659
Net income 1 -0.2123 0.0411 -1.491 -3.371 5.492 -1.189
Net margin - 0.35% -26,042.3% 199.52% 5.73% -1,351.14%
EPS 2 -0.003213 0.000622 -0.0226 -0.0510 0.0831 -0.0169
Free Cash Flow 1 -0.3602 -17.81 49.5 -2.681 -1.445 -1.169
FCF margin - -150.97% 864,802.46% 158.65% -1.51% -1,328.69%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 10/16/18 8/22/19 8/24/20 8/26/21 8/29/22 9/4/23
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - 0.7 0.76
Net Cash position 1 0.32 0.18 0.25 0.19 - -
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -0.36 -17.8 49.5 -2.68 -1.44 -1.17
ROE (net income / shareholders' equity) -0.38% 0.07% -2.71% -6.41% 10.2% -2.13%
ROA (Net income/ Total Assets) -0.24% 0.05% -1.59% -3.62% 3.9% -1.18%
Assets 1 89.93 89.59 93.49 93.2 140.9 101.2
Book Value Per Share 2 0.8400 0.8400 0.8200 0.7700 0.8500 0.8400
Cash Flow per Share 2 0 0 0 0 0 0
Capex - - - - - -
Capex / Sales - - - - - -
Announcement Date 10/16/18 8/22/19 8/24/20 8/26/21 8/29/22 9/4/23
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Shell Companies

1st Jan change Capi.
AMERISE BIOSCIENCES LIMITED Stock Amerise Biosciences Limited
-10.00% 501K
TRUMP MEDIA & TECHNOLOGY GROUP CORP. Stock Trump Media & Technology Group Corp.
+161.77% 6.26B
CHURCHILL CAPITAL CORP VII Stock Churchill Capital Corp VII
+2.33% 984M
APPLE ISPORTS GROUP, INC. Stock Apple iSports Group, Inc.
+41.91% 872M
PERELLA WEINBERG PARTNERS Stock Perella Weinberg Partners
+30.25% 851M
ARES ACQUISITION CORPORATION II Stock Ares Acquisition Corporation II
+1.72% 664M
E7 GROUP Stock E7 Group
+5.03% 648M
DA ZHONG TRADING GROUP HOLDING COMPANY Stock Da Zhong Trading Group Holding Company
-.--% 600M
ADMIRAL ACQUISITION LIMITED Stock Admiral Acquisition Limited
+12.78% 548M
CAPITOL INVESTMENT CORP. VII Stock Capitol Investment Corp. VII
-.--% 500M
Shell Companies
  1. Stock Market
  2. Equities
  3. AMARDEE6 Stock
  4. Financials Amerise Biosciences Limited